MedPath

KILIMANJARO CLINICAL RESEARCH INSTITUTE

🇹🇿Tanzania
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:3

Trial Phases

5 Phases

Phase 1:2
Phase 2:1
Phase 3:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (37.5%)
Phase 1
2 (25.0%)
Phase 2
1 (12.5%)
Phase 3
1 (12.5%)
Phase 4
1 (12.5%)

Reducing Respiratory Distress After Elective Caesarean Birth Through Knee-chest-flexion: a Randomized Controlled Trial

Not Applicable
Recruiting
Conditions
Transient Tachypnea of the Newborn
First Posted Date
2024-02-21
Last Posted Date
2024-02-21
Lead Sponsor
Kilimanjaro Clinical Research Institute
Target Recruit Count
562
Registration Number
NCT06270823
Locations
🇹🇿

Kilimanjaro Christian Medical Centre, Moshi, Kilimanjaro, Tanzania

Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic

Phase 1
Completed
Conditions
Clinical Trial
Interventions
Drug: Evaluation of high dose rifampicin in children
First Posted Date
2020-06-18
Last Posted Date
2024-02-15
Lead Sponsor
Kilimanjaro Clinical Research Institute
Target Recruit Count
31
Registration Number
NCT04437836
Locations
🇹🇿

Kilimanjaro Clinical Research Institute, Moshi, Kilimanjaro, Tanzania

🇹🇿

Hydom Hospital, Babati, Manyara, Tanzania

🇹🇿

Mt. Meru Hospital, Arusha, Tanzania

and more 1 locations

The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy

First Posted Date
2013-07-24
Last Posted Date
2013-07-24
Lead Sponsor
Kilimanjaro Clinical Research Institute
Target Recruit Count
250
Registration Number
NCT01906788
Locations
🇹🇿

Bagamoyo Research and Training Centre, Bagamoyo, Tanzania

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.